August 2025 ZOHU Call/Webinar

What to know

  • A video recording of this webinar is posted below. Visit CDC TRAIN to get free continuing education (CE) for this webinar.

1 hour

Aug 6, 2025

Webinar details

Presentation topics

  • You Otter be Kidding Me: One Health Investigation into Tularemia from Marine Mammals
  • Occupational Exposure to Animals with Tularemia
  • Time to Talk Ticks—Ehrlichiosis in the United States

Featuring

Hanna Oltean, PhD, MPH | Presenter
Senior Epidemiologist, Zoonotic & Vector-borne Disease Program Lead
Washington State Department of Health
Dyanna Lambourn | Presenter
Marine Mammal Research Biologist and Licensed Veterinary Technician
Washington State Department of Fish & Wildlife
Laura Platt, MD | Presenter
Epidemic Intelligence Service Officer 
Bacterial Diseases Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention
Johanna S. Salzer, DVM, PhD | Presenter
Veterinary Medical Officer, Epidemiology Team Lead
Rickettsial Zoonoses Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention

Continuing Education (CE)

Visit CDC Train to receive continuing education (CE).

Webcast (Live)

  • Course Name: WC4565R-080625
  • Registration Code: ZOHUwebcast
  • Start Date: August 6, 2025
  • End Date: September 8, 2025

Web-on-Demand (Recording)

  • Course Name: WD4565R-080625
  • Start Date: September 9, 2025
  • End Date: September 9, 2027

Series objectives

1. Identify an implication for human, animal, and environmental health.

2. Identify a One Health approach strategy for prevention of public health threats.

3. Identify a One Health approach strategy for detection of public health threats.

4. Identify a One Health approach strategy for responding to public health threats.

5. List two ways to improve collaborative practice across the public healthcare team.

Disclosures

In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies over the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.

CDC, our planners, and presenters wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept commercial or in-kind support for this activity.

Resources